| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/07/2013 | US20130034528 New methods for isolating tr1 cells |
| 02/07/2013 | US20130034519 Organic compounds and their uses |
| 02/07/2013 | US20130034518 Interleukin-12 P40 Variants with Improved Stability |
| 02/07/2013 | US20130034517 Targeted drug phosphorylcholine polymer conjugates |
| 02/07/2013 | US20130034501 Diarylhydantoin compounds |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | CA2848369A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | CA2844058A1 Quinazoline compounds as serine/threonine kinase inhibitors |
| 02/07/2013 | CA2844042A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844040A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844038A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844037A1 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
| 02/07/2013 | CA2844034A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844032A1 Method for treating cancer by combined use of drugs |
| 02/07/2013 | CA2844030A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843809A1 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one |
| 02/07/2013 | CA2843595A1 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
| 02/07/2013 | CA2843338A1 Selective inhibition of malt1 protease by phenothiazine derivatives |
| 02/07/2013 | CA2842493A1 Crizotinib for use in the treatment of cancer |
| 02/07/2013 | CA2842368A1 Switch costimulatory receptors |
| 02/07/2013 | CA2842362A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | CA2842276A1 Pharmaceutical composition of oxidised avidin suitable for inhalation |
| 02/07/2013 | CA2839805A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/06/2013 | EP2554544A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2553101A2 Protease activated cytokines |
| 02/06/2013 | EP2552966A1 Antibodies against csf-1r |
| 02/06/2013 | EP2552959A2 Antibodies to muc16 and methods of use thereof |
| 02/06/2013 | EP2552957A1 Antibodies with enhanced or suppressed effector function |
| 02/06/2013 | EP2552922A1 Substituted pyrrolotriazines as protein kinase inhibitors |
| 02/06/2013 | EP2552914A1 Benzonaphthyridinamines as autotaxin inhibitors |
| 02/06/2013 | EP2552907A1 Pyridyltriazoles |
| 02/06/2013 | EP2552905A1 B-raf kinase inhibitors |
| 02/06/2013 | EP2552887A2 Indolyl or indolinyl hydroxamate compounds |
| 02/06/2013 | EP2552547A1 Materials and methods related to modulation of mismatch repair and genomic stability by mir-155 |
| 02/06/2013 | EP2552481A1 Bispecific antibodies |
| 02/06/2013 | EP2552462A2 Ccn3 peptides and analogs thereof for therapeutic use |
| 02/06/2013 | EP2552453A2 Methods and compositions for treating or ameliorating cancer using gemcitabine-5'-elaidate |
| 02/06/2013 | EP2552452A1 Egfr inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer |
| 02/06/2013 | EP2552451A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and tumor initiating cells |
| 02/06/2013 | EP2552450A1 Use of novel pan-cdk inhibitors for treating tumors |
| 02/06/2013 | EP2552444A1 NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NMPRTase) INHIBITOR FOR GLIOMA THERAPY |
| 02/06/2013 | EP2552443A1 Improved treatment of renal cell carcinoma |
| 02/06/2013 | EP2552439A1 Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| 02/06/2013 | EP2552438A1 Methods of treatment of hepatocellular carcinoma |
| 02/06/2013 | EP2552428A1 Pkc inhibitors for the treatment of b-cell lymphoma having chronic active b-cell-receptor signalling |
| 02/06/2013 | EP2552415A1 Methods of treating cancer |
| 02/06/2013 | EP2552216A1 Derivatives of 1-amino-2-cyclopropylethylboronic acid |
| 02/06/2013 | EP2514761A9 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 02/06/2013 | CN1378445B Drug releasing biodegradable fiber implant |
| 02/06/2013 | CN102918146A Method for producing tumor cell |
| 02/06/2013 | CN102918118A Fluorescent dye material and use thereof |
| 02/06/2013 | CN102918061A Antibodies against human CSF-1R and uses thereof |
| 02/06/2013 | CN102918060A Antibodies against human CSF-1R and uses thereof |
| 02/06/2013 | CN102918059A Anti-CD27 antibody |
| 02/06/2013 | CN102918045A Substituted pyrrolotriazines as protein kinase inhibitors |
| 02/06/2013 | CN102918043A Pyrrolopyrimidine compounds as inhibitors of CDK4/6 |
| 02/06/2013 | CN102918040A Purinone derivative |
| 02/06/2013 | CN102917726A Interferon analogs |
| 02/06/2013 | CN102917725A Cancer therapy method |
| 02/06/2013 | CN102917723A Soybean protein hydrolysate-containing antioxidant and use thereof |
| 02/06/2013 | CN102917717A Anti-tumor composition |
| 02/06/2013 | CN102917694A Tablet formulation of ezatiostat |
| 02/06/2013 | CN102914658A Application of CRISP3 protein on diagnosis and treatment of prostate cancer |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911938A siRNA (si Ribonucleic Acid) sequence for targeted restrain of POLD1 genetic expression |
| 02/06/2013 | CN102911877A Marine fungi cladosporium sphaerospermum and application thereof |
| 02/06/2013 | CN102911876A Marine fungus mucor circinelloides and application thereof in preparation of antineoplastic drugs |
| 02/06/2013 | CN102911279A Polysaccharide-peptide and liposome thereof |
| 02/06/2013 | CN102911261A Agrocybe aegerita lectin AAL-2 and coding gene thereof, preparation method and application thereof |
| 02/06/2013 | CN102911197A Camptothecin silicone hybrid derivative, composition containing camptothecin silicone hybrid derivative and application thereof |
| 02/06/2013 | CN102911193A Zinc complex of 2-bromobenzaldehyde hydrazino sulfo-benzyl formate Schiff base and application thereof |
| 02/06/2013 | CN102911192A Method for preparing 2-bromobenzene-formaldehyde-condensed hydrazino-sulfo-benzyl formate-Schiff base zinc complex |
| 02/06/2013 | CN102911188A Sulfur-containing diindolyl diketopiperazine compounds and application thereof in preparing antineoplastic drugs |
| 02/06/2013 | CN102911182A Bromophenol compound and application thereof |
| 02/06/2013 | CN102911180A 8H-benzopyran[2,3-f]-4-ketone derivatives and preparation method and application thereof |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN102911177A 7-(4-chlorphenyl)-5,6-dihydro-7aH-benzo[h]1,2,4-triazolo[3,4-b]quinazoline-5,6-diketone and synthetic method thereof |
| 02/06/2013 | CN102911172A Heteroaryl pyrimidine derivatives and preparation method and application thereof |
| 02/06/2013 | CN102911163A Quinazoline derivatives, composition containing derivatives and pharmaceutical application of derivatives |
| 02/06/2013 | CN102911157A (E)-3-[2-bromo-5-(3-substituted propoxy)]phenyl-N-{4-methyl-3-[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl acrylamide compound |
| 02/06/2013 | CN102911118A Benzo-azepine type derivative and preparation method and purpose thereof |
| 02/06/2013 | CN102908631A Function of actin 84 lysine monomethylation in cytokinesis and cell proliferation as well as application thereof to drug development |
| 02/06/2013 | CN102908626A Method for preparing chitosan/ transparent acid derivative nanofiber composite film through freezing drying technology |
| 02/06/2013 | CN102908622A Application of 5-LO (lipoxygenase) inhibitor for treatment of malignant tumor in blood system |
| 02/06/2013 | CN102908612A Applications of TRAIL truncated mutant in activating NF-kappaB and in inflammatory responses |
| 02/06/2013 | CN102908597A Greenhouse disease curing capsule |
| 02/06/2013 | CN102908581A Plaster for treating breast cancer and preparation method of plaster |
| 02/06/2013 | CN102908579A Traditional Chinese medicine preparation for treating gynecological diseases, liver diseases and prostatitis and preparation method of traditional Chinese medicine preparation |
| 02/06/2013 | CN102908529A Chinese medicament for treating lung cancer |
| 02/06/2013 | CN102908466A Propolis dropping pills and preparation method thereof |
| 02/06/2013 | CN102908464A Radix tetrastigme micro powder and preparation method and application thereof |
| 02/06/2013 | CN102908460A Oolong tea throat lozenge and preparation method thereof |
| 02/06/2013 | CN102908422A Potentilla discolor extract for reversing multidrug resistance of tumor, preparation method and application of potentilla discolor extract |
| 02/06/2013 | CN102908405A Traditional Chinese medicine composition of reversing tumor multi-drug resistance (MDR) and preparation method thereof |
| 02/06/2013 | CN102908382A Drug for treating tumors |
| 02/06/2013 | CN102908381A Fresh rhizoma bolbostemmae extract and preparation method thereof |
| 02/06/2013 | CN102908374A Method for extracting total saponin from kalopanax septemlobus leaves |